Q3 2024 13F Holders as of 9/30/2024
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
31.6M
-
Number of holders
-
249
-
Total 13F shares, excl. options
-
38.5M
-
Shares change
-
-780K
-
Total reported value, excl. options
-
$1.49B
-
Value change
-
-$25.9M
-
Put/Call ratio
-
0.36
-
Number of buys
-
137
-
Number of sells
-
-96
-
Price
-
$38.64
Significant Holders of COLLEGIUM PHARMACEUTICAL, INC - Common Stock, par value $0.001 per share (COLL) as of Q3 2024
273 filings reported holding COLL - COLLEGIUM PHARMACEUTICAL, INC - Common Stock, par value $0.001 per share as of Q3 2024.
COLLEGIUM PHARMACEUTICAL, INC - Common Stock, par value $0.001 per share (COLL) has 249 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 38.5M shares
.
Largest 10 shareholders include BlackRock, Inc. (5.52M shares), EVENTIDE ASSET MANAGEMENT, LLC (2.64M shares), Pacer Advisors, Inc. (2.59M shares), VANGUARD GROUP INC (2.35M shares), PRINCIPAL FINANCIAL GROUP INC (1.75M shares), RENAISSANCE TECHNOLOGIES LLC (1.66M shares), Invesco Ltd. (1.49M shares), STATE STREET CORP (1.37M shares), FULLER & THALER ASSET MANAGEMENT, INC. (1.37M shares), and Rubric Capital Management LP (1.25M shares).
This table shows the top 249 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.